FDA approves ‘Jascayd for progressive pulmonary fibrosis: What it means for patients

Exciting news for those affected by progressive pulmonary fibrosis (PPF): The US FDA has granted approval…

Study Shows Nerandomilast Slowed Lung Function Decline in Progressive Pulmonary Fibrosis

Nerandomilast (BI 1015550) is an investigational oral drug that selectively inhibits phosphodiesterase 4B, exhibiting antifibrotic and…